Liver Transplantation (DBCOND0029461)

Identifiers

Synonyms
Liver Transplants / Transplantation, Liver / Transplant, Liver / Hepatic Transplantation / Hepatic transplant / Liver Transplant / Liver Transplant Candidates / Liver transplantation / Transplantation of liver (procedure)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Ledipasvir
A direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents.
Mycophenolate mofetil
An inosine monophosphate dehydrogenase inhibitor used to prevent the rejection of kidney, heart, or liver transplants.
Sofosbuvir
A direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents.
Terlipressin
A drug used to treat bleeding caused by esophageal varices.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05106322
Estimation of Steatosis on Liver Transplants by Intraoperative SpectrometryNo drug interventionsNot AvailableNot Availablerecruiting
NCT04200846
Frailty in Liver Transplant Exercise (FLEX) TrialNo drug interventionstreatmentNot Availablewithdrawn
NCT02356939
Removable Intraductal Stenting in Duct-to-duct Biliary Reconstruction in Liver TransplantationNo drug interventionspreventionNot Availableterminated
NCT00178425
PK of MMF in Cadaveric vs Living Donor Liver Transplant RecipientsNo drug interventionstreatment4completed
NCT00117689
Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant Rejectionprevention2completed
NCT02498977
Liver Immunosuppression Free Trialhealth_services_research4terminated
NCT00166556
A Trial to Assess Campath-1H and Tacrolimus Followed by Immunosuppression Withdrawal in Liver Transplantationtreatment2completed
NCT02883400
Spironolactone After Liver Transplanttreatment4completed
NCT05835882
Blood Salvage From Liver Donors: a Feasibility Pilot StudyNo drug interventionssupportive_careNot Availablerecruiting
NCT06341543
Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)No drug interventionsotherNot Availablerecruiting
NCT05594901
Impact of a Risk Stratification Tool on the Outcome of Liver Transplant Recipients Colonized With Carbapenem Resistant Enterobacteriaceae: an Observational StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT06608667
The Clinical Study Aims to Assess the Quality of Donor Livers Using Hyperspectral Imaging.No drug interventionsNot AvailableNot Availablecompleted
NCT06591507
Perioperative Rehabilitation Therapy in Patients Undergoing Liver TransplantationNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT06601244
Pharmacokinetic Study in the Biliary Complications During Liver TransplantationNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01001403
Effect of Nafamostat on Postreperfusion Syndrome (PRS)prevention4completed
NCT01139203
Prophylaxis of Hepatitis B Virus Recurrence After Liver TransplantationpreventionNot Availableunknown_status
NCT00149890
Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative Steroidsprevention3completed
NCT03594864
Outcomes of Liver Transplantation in Low Weight Children After Reducing the Lateral Segment of a Living Donor, Adapting the Shape and Size of the Graft to the Needs of the RecipientNo drug interventionsNot AvailableNot Availablecompleted
NCT03371264
Data Collection Study From Donors and Recipients to Optimize Donor-recipient Matching in Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT00300521
Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular CarcinomaNo drug interventionstreatment2completed
NCT00531921
Effects of Donor and Recipient Genetic Expression on Heart, Lung, Liver, or Kidney Transplant SurvivalNo drug interventionsNot AvailableNot Availablecompleted
NCT01073202
Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver TransplantationtreatmentNot Availablecompleted
NCT00545402
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.treatment4completed
NCT06279884
A Cohort Study on the Pathogen Spectrum of Liver Transplant Recipients Complicated With InfectionNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05339984
Hepatic and Systemic Hemodynamic Modeling During Liver SurgeryNo drug interventionsbasic_scienceNot Availablerecruiting
NCT01137084
Liver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without SteroidstreatmentNot Availablecompleted
NCT03374579
co2 Gap and co2/o2 Ratio in Liver Transplant PatientsNo drug interventionsdiagnosticNot Availableunknown_status
NCT05890079
External Oblique Intercostal Plane Block for Liver Transplantation DonorsNo drug interventionsotherNot Availablecompleted
NCT01271179
Study of Sequential Perfusion of Liver Grafts to Prevent Nonanastomotic Biliary Strictures After Liver TransplantationNo drug interventionspreventionNot Availablecompleted
NCT03241043
Study to Evaluate Pharmacokinetic and Bioavailability of Envarsus® vs. Advagraf® in Liver Transplant Recipientstreatment3completed
NCT01448343
Effect of Rapid Transfusion With Fluid Management System 2000® (FMS)No drug interventionsdiagnosticNot Availablecompleted
NCT04475887
Treatment of Anemia With Intravenous Iron in Patients Listed for Orthotopic Liver Transplantationtreatment4unknown_status
NCT00778687
Heart Rate Variability Change After Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT05647733
Restrictive Fluid Management In Liver Transplantation (REFIL)No drug interventionstreatmentNot Availablerecruiting
NCT04661254
Treg Cell Therapy in Liver and Kidney Transplantation - Preclinical Validation of Batches of Treg Cells Amplified in VitroNo drug interventionsotherNot Availablenot_yet_recruiting
NCT05144451
Transcranial Doppler During Liver TransplantationNo drug interventionsscreeningNot Availableunknown_status
NCT00890253
Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantationtreatment2unknown_status
NCT06539377
Living Donor Liver Transplantation for Intrahepatic CholangiocarcinomaNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT01625377
A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver Transplant Recipientstreatment3completed
NCT03216447
A Study of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplanttreatment4recruiting
NCT00477347
Closed-loop Anesthesia, Using Bispectral Index as the Control Variable, During Liver TransplantationNo drug interventionstreatment4terminated
NCT01034345
Effect of Rapamycin on Tolerance-related Biomarkers on Stable Liver Transplant Recipientstreatment2unknown_status
NCT00333645
Prophylaxis With Caspofungin in High-Risk Liver Transplantationprevention2unknown_status
NCT00619398
A Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf® in Stable Liver Transplantation Patientstreatment3completed
NCT01011205
Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver Transplantationtreatment3completed
NCT06302205
A Home-based Exercise and Physical Activity Intervention After Liver Transplantation: Impact of Exercise IntensityNo drug interventionstreatmentNot Availablerecruiting
NCT05866783
Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availablerecruiting
NCT02174783
Mediterranean Diet and Protein-Sparing Modified Diet for Metabolic Syndrome in Liver Transplant RecipientsNo drug interventionstreatmentNot Availableterminated
NCT04107883
Effect of Transfusion of Plasma on Endothelial During Liver TransplantationNo drug interventionstreatmentNot Availablerecruiting
NCT03094728
Role of Human Leukocyte Antigen Matching in Liver Transplantation and Its Relation to OutcomesNo drug interventionsNot AvailableNot Availablecompleted
NCT02877628
Immunosuppressive Therapy Optimization: Development of a Population Pharmacokinetic-pharmacodynamic (PK-PD) Model in Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT04941911
A Feasibility Study of Octreotide Infusion During Liver Transplant.other2active_not_recruiting
NCT04728971
To Evaluate the Efficacy and Safety of Micafungin in Preventing Invasive Mycosis After Liver Transplantationprevention4not_yet_recruiting
NCT05588271
A New Prediction Mode for Predicting the Risk of Pressure Injury in Patients Undergoing Liver TransplantationNo drug interventionsNot AvailableNot Availablerecruiting
NCT02522871
OCS Liver PROTECT Trial: Preserving and Assessing Donor Livers for TransplantationNo drug interventionstreatmentNot Availablecompleted
NCT01887171
Evaluation of Preimplantation Portal Vein and Hepatic Artery Flushing With TacrolimuspreventionNot Availablecompleted
NCT05909371
Investigation of the Effects of Motor Cognitive Dual Task Exercises on Cognitive Function, Balance and Functional Capacity in Patients Who Have Undergone Liver Transplantation.No drug interventionssupportive_careNot Availablerecruiting
NCT00909571
Pharmacokinetics of Tacrolimus in Liver Transplantation Patients Treated With Prograf and Modified Release TacrolimusNot Available3completed
NCT00195988
Comparison of Immunosuppression Protocols After LTx in Childrentreatment4completed
NCT00008788
Osteoporosis in Children and Adults Following Liver TransplantationNo drug interventionsNot AvailableNot Availableunknown_status
NCT00295607
Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patientsprevention2completed
NCT02417207
Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence After Liver Transplantationtreatment4unknown_status
NCT02761109
Postoperative Complications After Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT04862156
WP02 Continued Access StudyNo drug interventionstreatmentNot Availableterminated
NCT02245256
Efficacy of Low-dose Dexmedetomidine to Prevent Delirium in Liver Transplant Patientsprevention4completed
NCT00282256
A Study of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant Patientsprevention2completed
NCT01425385
Autoregulation Assessment During Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT03995537
Monocytic Expression of HLA-DR After Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT04777032
The Danish Comorbidity in Liver Transplant Recipients StudyNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT01841632
Safety Study of Multipotent Progenitor Cells for Immunomodulation Therapy After Liver Transplantationtreatment1terminated
NCT02706132
Therapeutic Strategy and the Role of Mesenchymal Stromal Cells for ABO Incompatible Liver TransplantationNo drug interventionsprevention1 / 2unknown_status
NCT01379352
Vecuronium Requirements According to the Operation Phase During Liver Transplantation Under Desflurane AnesthesiaNo drug interventionsNot AvailableNot Availablecompleted
NCT00405652
Measurement of Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Liver Transplant Recipientstreatment3completed
NCT05876052
HOPE to Reduce Tumour Recurrence After LT In Patients With HCCNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT01428700
Gene Expression in Liver Allograft Rejection and Recurrent Hepatitis CNo drug interventionsNot AvailableNot Availablecompleted
NCT00147459
Immunogenicity of Booster Hepatitis B Vaccines in Children After Liver TransplantationNo drug interventionsdiagnosticNot Availableunknown_status
NCT06209775
Impact of Perioperative Body Composition Abnormalities on Patient Outcomes After Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT00718575
The Effects of Glucose/Ischemic Preconditioning on Reperfusion Injury in Deceased-Donor Liver TransplantationNo drug interventionstreatment3terminated
NCT05822570
Oxygen Dissociation Curve in Patients Undergoing Orthotopic Liver TransplantationNo drug interventionsNot AvailableNot Availablerecruiting
NCT04825470
Liver Transplantation for Unresectable GIST Liver MetastasesNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03596970
Study of the Effect of Everolimus Immunosuppressive Combination Therapies on Renal Function When Used as a Maintenance Treatment for Liver Transplant Patients.treatment3withdrawn
NCT00990470
Endoscopic Evaluation in Transplantation CandidatesNo drug interventionsNot AvailableNot Availablecompleted
NCT04551742
Social & Contextual Impact on Children Undergoing Liver TransplantationNo drug interventionsNot AvailableNot Availablerecruiting
NCT00320606
Withdrawal of Immunosuppression in Pediatric Liver Transplant RecipientsNo drug interventionstreatment1completed
NCT00080236
Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantationtreatment2completed
NCT04564313
Safety and Efficacy of Camrelizumab (Anti-PD-1 Antibody) in Recurrent HCC After Liver Transplantationtreatment1unknown_status
NCT02115113
REnal Function in Liver Transplantation: Everolimus With Calcineurin Inhibitor (CNI)-Sparing sTrategytreatment3completed
NCT01836718
Assessment of Intrahepatic Hepatitis C Virus (HCV) RNA Levels at the Time of Liver TransplantationNo drug interventionsNot AvailableNot Availableunknown_status
NCT00459719
A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Liver Transplantationprevention3completed
NCT02188719
Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantationtreatment1terminated
NCT04587024
A Study of mDOT for Immunosuppressant Adherence in Solid Organ Transplant RecipientsNo drug interventionsotherNot Availablecompleted
NCT03592524
Effect of Ramadan Fasting on Muslim Recipients After Living Donor Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT02118896
Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplanttreatment3completed
NCT02995096
Tumor Characteristics, Pre-transplant Treatments and Immunosuppression After Liver Transplantation for Hepatocellular CarcinomaNot AvailableNot Availablecompleted
NCT00585858
Cytokine Kinetics Test to Assess the Presence or Absence of Tolerance in Organ TransplantNo drug interventionsNot AvailableNot Availableterminated
NCT01128335
Efficacy, Safety, Tolerability, Pharmacokinetics of Sotrastaurin-tacrolimus vs. Mycophenolic Acid-tacrolimus in de Novo Liver Transplant Patientsprevention2completed
NCT03386435
The Effect of Remote Ischemic Preconditioning in Living Donor HepatectomyNo drug interventionspreventionNot Availablecompleted
NCT04672863
Mediterranean Diet Post-liver TransplantationNo drug interventionssupportive_careNot Availablerecruiting
NCT05448339
Tumor Feeding Vessels Deprivation Combined With Tyrosine Kinase Inhibitor in Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT06147648
Early Conversion of Prolonged-release Tacrolimus in Liver Transplantation.prevention4not_yet_recruiting
NCT03981848
Radiomics-based Non-invasive Classifier Research for HCC-related Liver TransplantationNo drug interventionsNot AvailableNot Availableunknown_status
NCT03500848
Sirolimus-based Immunosuppression Treatment Regimen for Liver Transplantationtreatment2 / 3unknown_status
NCT05209048
Risk Factors and a nOmogram of Venous thromboEmbolism in Patients After liveR Transplantation(ROVER Study)No drug interventionsNot AvailableNot Availablecompleted
NCT03147157
The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen After Liver TransplantationNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03243526
Effect of Fluid Management Guided by Pulse Pressure Variation Vs Central Venous Pressure on Lung Water Assessed by Lung Ultrasound During Liver TransplantationNo drug interventionssupportive_careNot Availablecompleted
NCT05526326
OrganOx Metra® New Enrollment PASNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00189826
A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Liver Transplantation.prevention3completed
NCT04030065
Study to Assess the Effect of Intravenous Supplementation of Omega-3 Fatty Acids on Outcome of Recipients in Living Donor Liver TransplantationNo drug interventionssupportive_care2unknown_status
NCT03976765
Interest of an Early Rehabilitation Program in Liver Transplant SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT02080065
Incidence, Risk Factors, and Risk Model of Acute Kidney Injury After Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT00321074
Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal Graftstreatment3completed
NCT02489474
Association of Genetic Polymorphism and Acute Kidney Injury After Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT01294020
Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®prevention2active_not_recruiting
NCT01125020
Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver TransplantationtreatmentNot Availableunknown_status
NCT01371331
A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantationprevention4completed
NCT06331273
Impact of "No-touch" Technique on the Outcome of Liver Transplantation for Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04572373
Supplements SMOF in TPN for Liver Transplantation RecipientsNo drug interventionsNot AvailableNot Availablecompleted
NCT02717273
Surgical Site Infections After Liver Transplantation Based on Perioperative AntibioticsNo drug interventionstreatment3completed
NCT00970073
Low Dose Thymoglobulin to Protect Kidney Function After Liver TransplantpreventionNot Availablecompleted
NCT01197573
Enhancing Donated After Cardiac Death (DCD) Utilization With Thrombolytic TherapypreventionNot Availablecompleted
NCT06472973
ADDICTOlogical Intervention in LIVEr Transplantation RecipientsNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT06188273
Impact of Skeletal Muscle Quality and Loss on the Outcome of Liver TransplantationNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02059460
Perioperative Evaluation of Terlipressin Infusion During Living Donor Liver Transplantation on Incidence of Acute Kidneyprevention4completed
NCT04793360
Molecular Assessment and Profiling of Liver Transplant RecipientsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00948194
Effect of Nitric Oxide (NO) on Ischemic/Reperfusion Injury During Extended Donor Criteria (EDC) Liver TransplantationtreatmentNot Availableterminated
NCT03140462
Influence of Genetic Polymorphism of Donor on Tacrolimus Concentration in Liver TransplantNo drug interventionsNot AvailableNot Availablecompleted
NCT00332462
A Study to Evaluate the Efficiency of Intravenously Administered Cyclosporine in de Novo Liver Transplant Recipientstreatment4completed
NCT05355662
Prognosis Analysis of Elderly Donor Liver in Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT04189380
Therapeutic Literacy Evaluation in Liver Transplanted PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT02533180
Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver TransplantationNo drug interventionstreatment2completed
NCT04511429
COVID-19 in Immunosuppressed ChildrenNo drug interventionsNot AvailableNot Availableunknown_status
NCT00267189
RESCUE Study - Everolimus in Liver Transplantation Recipients With Renal Insufficiencytreatment3completed
NCT00228592
HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infectionprevention2terminated
NCT01371344
A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipientsprevention4terminated
NCT03617744
Sleeve Gastrectomy for Morbid-Obesity Sequelae After TransplantationNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT06534840
Evaluation of Pulmonary Complications in Liver Transplantation Patients Based on Machine LearningNo drug interventionsNot AvailableNot Availablerecruiting
NCT03024840
Anaesthetic and Pediatric Living Related Liver TransplantationpreventionNot Availableunknown_status
NCT01909401
Pilot Study With Peginterferon, Ribavirin, and Boceprevir Prior to Transplantation to Clear Virus in Hepatitis C Genotype 1 Infected Individuals Undergoing Orthotopic Liver Transplantationtreatment0completed
NCT03694301
Physiological Data Analysis of Patients Undergoing Anesthesia for Liver TransplantationNo drug interventionsNot AvailableNot Availableunknown_status
NCT05089604
Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulationstreatment4recruiting
NCT05854472
Using Smartphone Application After Liver TransplantationNo drug interventionssupportive_careNot Availablerecruiting
NCT00879268
Vasosol Organ Perfusion Solution and Medtronic Portable Bypass SystemNo drug interventionstreatment1completed
NCT01824368
Extracorporeal Photopheresis in Liver Transplantation. Phase II Clinical Trial in Safety and Efficacy in Patients With Gradual Decrease of Immunosuppression.No drug interventionstreatment1 / 2completed
NCT03910868
Impact of P-gp, MRP2, ENT-1 and CNT3 on the Blood Concentration / Intra-PBMC Concentration of TacrolimusNo drug interventionsNot AvailableNot Availablecompleted
NCT00668369
Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver TransplantationNo drug interventionstreatment2completed
NCT03465969
A Study to Compare the Finger Prick Whole Blood MITRA Assay Method With the Established Venepuncture Whole Blood Method for Quantitative Determination of Tacrolimus Blood Concentrations in Transplant Patientsother4completed
NCT00622869
Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipientstreatment3completed
NCT05680246
Long-term Outcomes After Prolonged Dual Hypothermic Oxygenated Machine Perfusion of Donor Livers (DHOPEPROLONG)No drug interventionsNot AvailableNot Availablerecruiting
NCT00367146
MMF After Pediatric Liver TransplantationNo drug interventionstreatmentNot Availablecompleted
NCT04472312
Portal Pressure Effects of Phlebotomy Combined to Vasopressin Use in Cirrhotic Patients Undergoing Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT00682110
Hemodynamic Measurements During Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT03522181
Glucose-insulin-potassium Therapy Improves Lactic Acidosis in Liver TransplantationNo drug interventionstreatmentNot Availablecompleted
NCT05080595
Transportation Assistance Program for Liver TransplantNo drug interventionshealth_services_researchNot Availableenrolling_by_invitation
NCT01018914
A Study to Compare Safety and Efficacy of Prograf + Myfortic and Advagraf + Myfortic in Liver Transplantation Patientstreatment4completed
NCT02695823
Incidence of Intracranial Hypertension During Liver Transplantation Estimated by Non-invasive Ultrasound Methods.No drug interventionsdiagnosticNot Availablecompleted
NCT06424808
Pilot Study for the Validity of a Content-based Information Provision Tool Aimed at Improving the Hospitalization Experience of Liver Transplant PatientsNo drug interventionshealth_services_researchNot Availablenot_yet_recruiting
NCT02515708
Pilot Study to Assess Safety and Feasibility of Normothermic Machine Preservation In Human Liver TransplantationNo drug interventionstreatmentNot Availablecompleted
NCT01146808
Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive Livertreatment1 / 2completed
NCT03098043
Post-Static Cold Storage Hypothermic Oxygenated Perfusion in Bergamo Liver Transplant ProgramNo drug interventionsNot AvailableNot Availableunknown_status
NCT01120743
Correlation Between Release of Cytokines From Liver Graft and Hemodynamic InstabilityNo drug interventionsNot AvailableNot Availablecompleted
NCT00842803
Post-Operative Use of Salt Poor Albumin Solution in Resuscitation of Orthotopic Liver Transplantsupportive_careNot Availableunknown_status
NCT06564103
Stratification for F-L Therapy After LTNo drug interventionsNot AvailableNot Availablecompleted
NCT04814290
Long-term Follow-up of Living Liver Donors: A Single-center ExperienceNo drug interventionsNot AvailableNot Availablecompleted
NCT03176290
Non-Invasive Assessment of Graft Fibrosis After Living Donor Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT03152890
Insulin Therapy for Postreperfusion Hyperglycemiatreatment4recruiting
NCT04595864
Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma Beyond Milan/UCSF Criteria Who Underwent Liver TransplantationNo drug interventionstreatment3recruiting
NCT01886664
Comparison of PRS According to Inhalation Agent During LDLTprevention4completed
NCT01672164
Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant RecipientsNo drug interventionsNot AvailableNot Availablecompleted
NCT03256864
Twice-daily Tacrolimus and Everolimus Convert to Once-daily Tacrolimus and Everolimus in Liver Transplant Recipientother4completed
NCT04348721
INTERNATIONAL SURVEY ON COMPLEXITY IN LIVER TRANSPLANTATIONNo drug interventionsNot AvailableNot Availableunknown_status
NCT00402402
Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in Patients With Chronic Liver DiseaseNo drug interventionsdiagnostic4completed
NCT03222102
Ventral Hernia Prevention After Liver TransplantationNo drug interventionspreventionNot Availablerecruiting
NCT00678002
Quality of Life in Pediatric Transplant PatientsNo drug interventionsNot AvailableNot Availableterminated
NCT03103984
Immunosuppression and Diet: the Role of Inflammation in the Adipose Tissue RemodelingNo drug interventionsotherNot Availablecompleted
NCT04319484
Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombustreatment2 / 3not_yet_recruiting
NCT03456284
Safety and Feasibility of Normothermic Machine Perfusion to Preserve and Evaluate Orphan LiversNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT01065584
An Observational Study to Assess the Effect of Calcineurin Inhibitors on Markers of Transplant ToleranceNo drug interventionsNot AvailableNot Availableunknown_status
NCT00302484
Use of Bisphosphonates in the Treatment of Osteopathy After Liver TransplantationpreventionNot Availableunknown_status
NCT02143479
A Multicenter Study in Liver Transplant Patients Converted From Prograf® to Advagraf® During the First Post-transplantation YearNot AvailableNot Availablecompleted
NCT02556879
Immunization Anti HLA in the Liver Transplant Recipients (DSATH)diagnosticNot Availableunknown_status
NCT06354179
Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY)treatment4not_yet_recruiting
NCT03012633
Rapid Diagnostic of Hyperfibrinolysis in Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT03176433
Post Static Cold Storage Normothermic Machine Liver PerfusionNo drug interventionstreatment1 / 2unknown_status
NCT06290154
Factors Associated With Posttransplant Cardiac OutcomesNo drug interventionsNot AvailableNot Availablerecruiting
NCT04055051
ATHN 11: Liver Transplantation Outcomes StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT05666453
A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in ABO-Incompatible Liver Transplantationtreatment2terminated
NCT02432053
A Study to Demonstrate Safety and Efficacy of Advagraf in Patients Undergoing Kidney or Liver Transplantation in Indiatreatment4completed
NCT01117077
The Immune Tolerance Mechanism Induced by IL-17-producing Regulatory T Cells in the Orthotopic Liver Transplant Recipients With AspergillosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT03453047
S100β and Neuron Specific Enolase Levels in Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT02602847
Study of Covalently Closed Circular DNA (cccDNA) in Liver Transplant Patients With B Virus MarkersNo drug interventionsNot AvailableNot Availablecompleted
NCT00719745
A Study to Assess the Safety and Efficacy of Prograf and MR4 in Liver Transplant Recipientstreatment3completed
NCT06535945
Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantationtreatment4not_yet_recruiting
NCT00647283
Assessment Of the Safety and Benefit of Prospective Immunosuppressive Drug Withdrawal in Liver Transplantation and Prediction of Operational ToleranceNo drug interventionsdiagnostic2unknown_status
NCT05237583
Prehabilitation for Patients Awaiting Liver TransplantationNo drug interventionstreatmentNot Availablerecruiting
NCT03275883
Arterial Patency in Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT05574361
Continued Access Study to Evaluate Performance of the Organ Recovery Systems _LifePort® Liver Transporter System, a Machine Perfusion System, for Liver Transplant (PILOT™_CA)No drug interventionstreatmentNot Availablerecruiting
NCT05572528
Lenvatinib Therapy in HCC Patients After LDLTNo drug interventionsNot AvailableNot Availablerecruiting
NCT05152628
A Study of Modigraf® (Tacrolimus Granules) to Evaluate the Pharmacokinetics and Long-term Safety and Efficacy in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipientstreatment4completed
NCT00415311
A Multicenter Study Evaluating the Safety and Tolerability of Intravenous rhMBL in Liver Transplant Recipients.treatment1terminated
NCT00151593
Evaluation of Celsior® in Liver Transplant Preservation.No drug interventionstreatment2completed
NCT03820271
New Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver TransplantationNo drug interventionsotherNot Availableunknown_status
NCT01781871
Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Compared to the Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patientsprevention4completed
NCT06409507
Research and Application for New Clinical Diagnosis and Treatment System for HBV Related HCC Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT04230707
Endogenous Melatonin Levels on Anxiety in Living Liver DonorsNo drug interventionsNot AvailableNot Availableunknown_status
NCT06019507
A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantationprevention2recruiting
NCT00839709
Peripheral Immunologic Response of Solid Organ Transplant Recipients to Depletion Versus Non-depletion ProtocolsNo drug interventionsNot AvailableNot Availablecompleted
NCT03376009
A Study of Novel Biomarkers of Kidney Dysfunction at Liver TransplantNo drug interventionsNot AvailableNot Availablecompleted
NCT03966209
Safety and Efficacy of PD-1 Inhibitors in Patients With Liver Transplanttreatment1unknown_status
NCT00114556
The Effect of Zoledronic Acid on Bone Density in Liver Transplant Patientsprevention4completed
NCT00161356
Ambisome in Liver Transplant Patientsprevention4terminated
NCT01121185
Study in Hepatitis C Virus (HCV) Infected Patients Undergoing Liver Transplantation to Evaluate a Human Monoclonal Antibody Against Hepatitis Cprevention2terminated
NCT00646685
Duct-to-duct vs Roux-en-y Hepaticojejunostomy for Biliary Reconstruction in Adult Living Donor Liver TransplantationNo drug interventionsprevention4unknown_status
NCT02898415
Modeling Cancer-specific Prognosis in Liver Transplantation for Hepatocellular Carcinoma (HCC)No drug interventionsNot AvailableNot Availablecompleted
NCT01705015
Organ Transplantation Rehabilitation: Effect of Bedside Exercise Device and Activity ReinforcementNo drug interventionstreatmentNot Availableunknown_status
NCT05153915
A Study to Evaluate the Safety and Efficacy of a Modigraf® Based Immunosuppression Regimen in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipientstreatment4completed
NCT01888432
Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplantstreatment3completed
NCT00722332
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patientsprevention4completed
NCT00451932
A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant Patientstreatment2completed
NCT00364052
Prophylactic Therapy for Cytomegalovirus in Liver Transplant RecipientsNot AvailableNot Availableunknown_status
NCT03396159
Validity of Mini Fluid Challenge Post Liver TransplantationNo drug interventionsdiagnosticNot Availablecompleted
NCT01638559
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant RecipientsNo drug interventionstreatment2completed
NCT01023542
CNI-free "Bottom"-up Immunosuppression in Patients Undergoing Liver Transplantationtreatment2 / 3unknown_status
NCT05490342
Effect of SARS-CoV-2 Vaccination in Liver Transplant RecipientsNo drug interventionsNot AvailableNot Availablecompleted
NCT05754242
Ascorbic Acid to Prevent Postreperfusion Syndrome in Liver Transplantationprevention2recruiting
NCT00149942
Conversion Trial From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS) in Stable Transplanted Patients Suffering From Gastrointestinal (GI) Adverse Events While on Mycophenolate Mofetil Therapy (MMF) Therapytreatment4completed
NCT00118742
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplanttreatment4completed
NCT06085599
The Effect of Exercises on Pain and Kinesiophobia in Transplant PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT01046799
Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavirtreatment3completed
NCT04274699
Clinical Evaluation of the Hemosonics Quantra® Coagulation Monitor in Liver and Multivisceral TransplantationNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00378599
Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED)treatment3completed
NCT05326399
Renal Biopsies in Post-liver Transplantation Patients With Renal ImpairmentNo drug interventionsNot AvailableNot Availablerecruiting
NCT02544906
Propofol Versus Dexmedetomidine for Prevention of Sevoflurane Agitation in Recipients of Living Donor Liver TransplantationpreventionNot Availableunknown_status
NCT01445236
Pilot Study of Immunosuppression Drug Weaning in Liver Recipients Exhibiting Biomarkers of High Likelihood of ToleranceNo drug interventionstreatmentNot Availableterminated
NCT05475613
Downstaging Protocol Containing Immunotherapy for HCC Beyond the Milan Criteria Before Liver TransplantationNo drug interventionstreatment2recruiting
NCT02784119
APCext : Effect of Temporary Porto-caval Shunt During Liver Transplantation on Function of Liver Graft From Extended Criteria DonorNo drug interventionsotherNot Availablerecruiting
NCT02890719
Pilot Study Evaluate Efficacy of Grazoprevir + Elbasvir for 12 or 16 Weeks in Liver Transplant Recipients.treatment3withdrawn
NCT02423941
A Study of Retrograde rEperfusion in Dbd Donor LIver TransplantationNo drug interventionspreventionNot Availableunknown_status
NCT01207141
rATG Induction and Tacrolimus Monotherapy in Pediatric Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT05589441
Nebulized Salbutamol Facilitate Management of Hyperkalemia Postreperfusion During Liver TransplantationtreatmentNot Availableunknown_status
NCT01299441
Endotracheal Cardiac Output Monitor (ECOM) for Patients Undergoing Liver TransplantationNo drug interventionsNot AvailableNot Availableterminated
NCT04444817
Evaluation of the Impact of Tacrolimus-based Immunosuppression on Heidelberg Liver Transplant Cohort (HDTACRO): Study Protocol for an Investigator Initiated, Non-interventional Prospective StudyNot AvailableNot Availableunknown_status
NCT01457534
The Predictors for Continuous Renal Replacement Therapy in Liver Transplant PatientNo drug interventionsNot AvailableNot Availablecompleted
NCT00693524
Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TXtreatment2completed
NCT02995824
Effectiveness of Raltegravir-Based Antiretroviral Therapy in HIV-HCV Coinfected Liver Transplant RecipientsNo drug interventionsNot AvailableNot Availablecompleted
NCT06371924
Immunometabolism of Machine Perfusion StrategiesNo drug interventionsotherNot Availablenot_yet_recruiting
NCT02839616
Institutional Registry of Liver TransplantationNo drug interventionsNot AvailableNot Availableunknown_status
NCT04261816
Early Extubation and Postoperative Complications After Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT00209196
Quality of Life in Pediatric Transplant RecipientsNo drug interventionsNot AvailableNot Availablecompleted
NCT05752058
Risk Factors for Early Acute Lung Injury After Liver Transplantation in ChildrenNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02909335
De Novo Everolimus Versus Tacrolimus in Combination With Mofetil Mycophenolate and Low Dose Corticosteroids to Reduce Tacrolimus Induced Nephrotoxicity in Liver Transplantation: a Prospective, Multicentric, Randomised Studyprevention3withdrawn
NCT05760235
Prospective Pilot Study for the Evaluation of Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Liver Transplant CandidatesNo drug interventionstreatmentNot Availablerecruiting
NCT04778735
Investigation of Mortality, Morbidity and Risk Factors After Pediatric Liver TransplantationNo drug interventionstreatmentNot Availablecompleted
NCT00456235
Reduction in the Risk of Rejection by Mycophenolate Mofetil Dose Adjustment in Liver Transplant Patients With Side Effects Caused by the Calcineurine Inhibitorstreatment4completed
NCT00105235
Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patientstreatment2completed
NCT04180735
Intestinal Perforation in Patients Receiving an Orthtopic Liver Transplantation in the Montpellier University HospitalNo drug interventionsNot AvailableNot Availablecompleted
NCT01655563
Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantationtreatment2completed
NCT01216722
Study of Resistance Strengthening Versus Ambulation Post-Liver TransplantNo drug interventionstreatmentNot Availablecompleted
NCT02707822
The Influence of ABCB1、CYP3A4、CYP3A5、POR Genetic Polymorphism and Other Factors on Tacrolimus Blood ConcentrationNo drug interventionsNot AvailableNot Availableunknown_status
NCT03423225
To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant Recipientsscreening4completed
NCT03806725
Safety of Iodinated Contrast in Liver Transplant Candidates With Decreased Renal Function Undergoing Coronary CT AngiographyNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00297830
Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantationprevention2 / 3completed
NCT03781830
mDOT for Immunosuppressant Adherence in Adolescent Liver Transplant RecipientsNo drug interventionssupportive_careNot Availablewithdrawn
NCT01654848
Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant RecipientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04559048
Investigation of Pain Incidence After FK506 Immunosuppressive Therapy in Liver Transplantation PatientsNot AvailableNot Availablerecruiting
NCT00343226
An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation.treatment4completed
NCT04764266
Glycocalyx During Normothermic Machine PerfusionNo drug interventionsbasic_scienceNot Availablecompleted
NCT03665766
Effect of Cyclosporine A Versus Tacrolimus on Response to Antiviral Therapy After Hepatitis C Genotype -4 Recurrence Post Liver TransplantationNot AvailableNot Availablecompleted
NCT03474666
Glycemic Control and Surgical Site Infection Incidence Among Liver Transplantation RecipientsNo drug interventionstreatmentNot Availableterminated
NCT00538265
Benefit of Immunoprophylaxis on Fibrosis to Reduce Viral Load After Liver Transplantationtreatment4completed
NCT01131065
Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipientsprevention3completed
NCT06217965
Evaluation of the Epidemiological and Psychosocial Outcomes of Liver Graft Recipients Transplanted During ChildhoodNo drug interventionsNot AvailableNot Availablerecruiting
NCT03133065
Early Treatment of Recurrent HCV- Infection Post Liver Transplantation in the Era of DAAsNo drug interventionstreatment4completed
NCT01614665
A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Timeother2completed
NCT03395574
Effect of Terlipressin on Cerebral Oxygen Saturation During Liver Transplantationtreatment2completed
NCT01058174
Liver Transplant European Study Into the Prevention of Fungal Infectionprevention3completed
NCT05520320
Long-term Outcomes After Hypothermic Oxygenated Machine Perfusion of Donor Livers Using Real-world DataNo drug interventionsNot AvailableNot Availablecompleted
NCT00170131
MMF Influence on HCV Viral Evolution After Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT04761731
To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant Recipientsscreening4completed
NCT00374231
Single Center Pilot Study of Corticosteroid Discontinuation in Liver Transplant Recipientstreatment4completed
NCT04023773
Sequential Hypo- and Normo-thermic Perfusion to Preserve Extended Criteria Donor Livers for TransplantationNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT01944527
Use of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) InfectionNo drug interventionsNot AvailableNot Availableunknown_status
NCT02736227
Biomarkers Predicting Successful Tacrolimus Withdrawal and Everolimus (Zortress) Monotherapy Early After Liver TransplantationtreatmentNot Availablecompleted
NCT03800576
Clinical Outcome of Liver Transplant Patients With Tacrolimus-based ImmunosuppressionNo drug interventionsNot AvailableNot Availablecompleted
NCT00938860
Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis Ctreatment4completed
NCT06162260
Unplanned ICU Readmission for Pediatric Liver TransplantationNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06331260
Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01890460
Evaluation of Liver Disease With Elastography Measurements in Patients Undergoing Liver Transplant SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT04488094
Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver TransplantationNo drug interventionsdiagnostic2completed
NCT00295594
Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.prevention3completed
NCT03786991
EPI-STORM: Cytokine Storm in Organ DonorsNo drug interventionsNot AvailableNot Availablerecruiting
NCT02775162
WP01 - Normothermic Liver PreservationNo drug interventionstreatmentNot Availablecompleted
NCT01664780
Acoustic Radiation Force Impulse Imaging (ARFI) in Patients After Liver TransplantationNo drug interventionsNot AvailableNot Availableunknown_status
NCT02412280
Validity of Different Prognostic Models Assessing 1 Year Survival After Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT00151580
Treatment of Recurrent Hepatitis C After Liver Transplantationdiagnostic3completed
NCT00585429
Evaluation of Kidney Disease in Liver Transplant RecipientsNo drug interventionsNot AvailableNot Availablewithdrawn
NCT02697929
Sugammadex/Neostigmine and Liver TransplantationotherNot Availablecompleted
NCT03228329
Validation of Cardiometry in Resuscitation of Patients Undergoing Liver TransplantationNo drug interventionsdevice_feasibilityNot Availablecompleted
NCT00408889
Prospective Evaluation of Predictors for Organ Failure Following Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT00167492
Enteric Coated Myfortic for Liver Transplant Recipientstreatment4withdrawn
NCT03985644
Multi-center Clinical Application of Hangzhou Criteria in Liver Transplantation for Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availableunknown_status
NCT04237740
Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver TransplantationNo drug interventionstreatment3unknown_status
NCT04622540
EBD RCT Trial in Living Donor Liver TransplantationNo drug interventionspreventionNot Availablerecruiting
NCT06382740
Selection Protocol for Liver Transplantation in Patients Aged Over 70 YearsNo drug interventionsNot AvailableNot Availablerecruiting
NCT03983967
Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver TransplantationNo drug interventionstreatment1 / 2completed
NCT03165201
Non-Invasive Rapid Assessment of Patients With Liver Transplants Using Magnetic Resonance Imaging With LiverMultiScanNo drug interventionsNot AvailableNot Availablecompleted
NCT04203004
HOPE With Cytokine Filtration in Liver Transplantation (Cyto-HOPE)No drug interventionstreatmentNot Availablerecruiting
NCT00701272
FGL2/Fibroleukin and Hepatitis C Virus Recurrence Post Liver TransplantationNo drug interventionsNot AvailableNot Availableunknown_status
NCT03123172
The Validity of Central Venous to Arterial Co2 Difference During Living Donor Liver TransplantationNo drug interventionsdiagnosticNot Availablecompleted
NCT01339468
A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver Transplantationtreatment4completed
NCT03363646
Italian National Study on the Critically Ill Liver Transplant Patient With an InfectionNo drug interventionsNot AvailableNot Availableunknown_status
NCT00086346
Study Evaluating of Calcineurin Inhibitor and Sirolimus (Rapamune) Treatment in Liver Transplant Recipientstreatment3terminated
NCT01551212
Efficacy of Everolimus in Combination With Tacrolimus in Liver Transplant Recipientstreatment4completed
NCT01321112
Search for Transcriptional Biomarkers in a Conversion Protocol From Calcineurin Inhibitors to Mycophenolate MofetilNo drug interventionsdiagnosticNot Availableunknown_status
NCT02739412
Efficacy of Low Dose, SubQ Interleukin-2 (IL-2) to Expand Endogenous Regulatory T-Cells in Liver Transplant Recipientstreatment2completed
NCT04376281
The Effect of Norepinephrine on Cardiac Output in Patients Undergoing Liver Transplant .treatmentNot Availablecompleted
NCT02352181
Management of Coagulopathy During Orthotopic Liver Transplantation. Comparison Between ROTEM-based Management and Standard Biological Assessment.No drug interventionssupportive_careNot Availablecompleted
NCT00378014
Preservation of Renal Function in Liver Transplant Recipients With Certican Therapytreatment3completed
NCT01198314
Withdrawal of Immunosuppression in Long Term Stable Liver Transplant RecipientsNo drug interventionstreatment2unknown_status
NCT00717314
A Study of CellCept (Mycophenolate Mofetil) Combined With Calcineurin Inhibitors in Liver Transplant Patients.treatment4completed
NCT03484455
Study to Evaluate Performance of the Organ Recovery Systems LifePort® Liver Transporter System, a Machine Perfusion System, for Liver TransplantNo drug interventionstreatmentNot Availablecompleted
NCT02460250
Evaluation of Liver Grafts With FibroScan® Before Organ Retrieval in Patients With Brain DeathNo drug interventionsdiagnosticNot Availablecompleted
NCT04762550
Thrombin Generation in Liver Transplant SurgeryNo drug interventionsNot AvailableNot Availableunknown_status
NCT03929523
Hypothermic Oxygenated Perfusion for Extended Criteria Donors in Liver Transplantation (HOPExt)No drug interventionstreatmentNot Availablecompleted
NCT02123108
Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA (Enteric Coated Mycophenolic Acid) Following Liver Transplantationtreatment4completed
NCT02740608
Viability Testing and Transplantation of Marginal LiversNo drug interventionstreatmentNot Availablecompleted
NCT06307808
Viral Immunity in Solid Organ Transplant Recipients: Monitoring Of The Response To Hepatitis B Booster VaccinationNot AvailableNot Availablenot_yet_recruiting
NCT00720408
A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.treatment3completed
NCT01176708
Intact Liver Innervation and Glucose and Glucagon-like Peptide-1 (GLP-1) Induced Insulin Secretionbasic_scienceNot Availableunknown_status
NCT00564538
A Study of Thymoglobulin and Tacrolimus in Liver Transplanttreatment4unknown_status
NCT00282243
A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patientsprevention2completed
NCT05047406
Bacillus Clausii in Liver TransplantationNo drug interventionsprevention2active_not_recruiting
NCT02853981
Clamp-crush Technique Versus Harmonic Scalpel in Living Donor HepatectomyNo drug interventionstreatment2 / 3completed
NCT01388387
Pharmacogenetic Study of Tacrolimus in Hepatic Transplant (CYPTAC'H)No drug interventionstreatmentNot Availablecompleted
NCT03174327
Evaluation of Hepatic Rigidity by Ultrasonic Impulse Elastography in Liver Transplant PatientsNo drug interventionsdiagnosticNot Availablecompleted
NCT06075745
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant CandidatesNo drug interventionstreatment2recruiting
NCT06611046
MicroRNA Profile As a Biomarker of Liver Damage in Different Types of Liver Donors.No drug interventionsNot AvailableNot Availablecompleted
NCT06222554
Examining the Use of a Novel Immersive Motion Tracking Upper Extremity Exercise Program for Acute Hospitalized PatientsNo drug interventionsdevice_feasibilityNot Availablerecruiting
NCT06280950
Expanding Liver Transplant Immunosuppression Minimization Via Everolimustreatment2recruiting
NCT06342557
Transitional EPRO Diary LiverNo drug interventionsNot AvailableNot Availablerecruiting
NCT06589518
To Evaluate the Efficacy and Safety of Tenofovir Alafenamide Conversion in Liver Transplant Patientsprevention2not_yet_recruiting
NCT01644903
Proteogenomic Monitoring and Assessment of Liver Transplant RecipientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04186221
OCS Liver PROTECT Continued Access ProtocolNo drug interventionstreatmentNot Availablecompleted
NCT01380002
Home-Care Needs in Liver or Renal Transplantation Recipients and Their SpousesNo drug interventionsNot AvailableNot Availableunknown_status
NCT02521584
Ischemia Time and Graft SurvivalNo drug interventionsNot AvailableNot Availableunknown_status
NCT03238443
Interest of the Donor-specific Antibodies After Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT04504487
Early Versus Routine Drain Removal After Live Liver Donor HepatectomyNo drug interventionsbasic_scienceNot Availablecompleted
NCT01598987
Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.treatment3completed
NCT05096754
OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT05051605
Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver TransplantationNo drug interventionsNot AvailableNot Availablerecruiting
NCT03555383
Individualized Multimodal Hemostasis Evaluation Pyramid (IMHOTEP)No drug interventionsNot AvailableNot Availablecompleted
NCT05327478
NRP vs DHOPE vs COR-NMP in ECD-DCD DonationNo drug interventionsNot AvailableNot Availablerecruiting
NCT04383756
Utilization of Donor Whole Blood for Blood Transfusion in Deceased Donor Liver TransplantationNo drug interventionstreatment0withdrawn
NCT00995956
Albumin, Total and Free Fraction of Mycophenolic Acid, and Measurement of IMPDH Activity in Liver Transplants.No drug interventionsNot AvailableNot Availablecompleted
NCT06409637
FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver Transplantationprevention1 / 2not_yet_recruiting
NCT03357900
Closed-loop Anaesthesia for Liver Transplantation: a Pilot StudyNo drug interventionstreatmentNot Availablecompleted
NCT03930459
Efficacy of Ex-situ Normothermic Perfusion Versus Cold Storage in the Transplant With Steatotic Liver Graft.No drug interventionspreventionNot Availableterminated
NCT00698399
Serum Markers of Ischemia Reperfusion Injury in Liver Transplant PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT02859506
Eating Behaviour and Gustatory Sensitivity Before and After Liver Transplant in Cirrhotic PatientsNo drug interventionsotherNot Availablecompleted
NCT05514119
A Study to Assess the Role of Fenofibrate in Preventing Ischemic Cholangiopathy After Liver Transplantationtreatment2recruiting
NCT03124641
HOPE for Human Extended Criteria and Donation After Brain Death Donor (ECD-DBD) Liver AllograftsNo drug interventionstreatmentNot Availablecompleted
NCT03411616
Eating Behavior, Food Craving and Relation to Excessive Weight Gain in Patients Submitted to Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT01307163
Systemic Variables in the Saliva of Children Undergoing Liver TransplantationNo drug interventionsNot AvailableNot Availableunknown_status
NCT02182986
Biomarkers for Post-Transplant Lymphoproliferative Disorders in ChildrenNo drug interventionsNot AvailableNot Availablecompleted
NCT03819322
The Use of Hepatitis C Positive Livers in Hepatitis C Negative Liver Transplant Recipientstreatment2active_not_recruiting
NCT06036225
PREPARE- Prehabilitation for Patients Awaiting Liver Transplantation: Feasibility and Acceptability Testing.No drug interventionssupportive_careNot Availablerecruiting
NCT03515330
A Pilot Study of mDOT for Immunosuppressant Adherence in Adult Liver Transplant RecipientsNo drug interventionssupportive_careNot Availablewithdrawn
NCT05940857
US National OCS Liver Perfusion (OLP) RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT04265157
Hepato-duodenal Ligament Occlusion and Classic Technique in Liver TransplantNo drug interventionsNot AvailableNot Availableunknown_status
NCT04069065
Efficacy and Safety of Once-Daily Tacrolimus in Liver Transplant Recipients (SOUL)treatment4unknown_status
NCT04867720
Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipientstreatment4unknown_status
NCT06043531
Targeting Trimethylamine N-Oxide for Cardiovascular Health In Liver Transplant RecipientsNo drug interventionstreatmentNot Availablerecruiting
NCT01172691
Trial of Inhaled Nitric Oxide (iNO) on Ischemia / Reperfusion Injury During Orthotopic Liver Transplantation With Marginal GraftsNo drug interventionsprevention2unknown_status
NCT03654040
Liver Transplantation With Tregs at UCSFtreatment1 / 2terminated
NCT03507140
Microbiota Study in Liver Transplanted PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04792801
PET TDM FDG-Choline as a Decision-making Tool for Routine Care on the Liver Transplant List for HCCNo drug interventionsNot AvailableNot Availablerecruiting
NCT06215404
Fluid Management Strategies on Blood Loss in Liver TransplantationNo drug interventionspreventionNot Availablerecruiting
NCT04089969
Cardiac Risk Assessment Using Standard of Care Versus CTA and Heart Flow FFRctNo drug interventionsdiagnosticNot Availablewithdrawn
NCT06357455
Platelet Count and Function After Usage of Two Different Cell Saver Devices During Liver Transplant SurgeryNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT05087550
Multicenter Study on Organ Acquisition Costs in the Post Re-Allocation Era: Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT04836923
LIFT Intervention in Liver Transplant CandidatesNo drug interventionspreventionNot Availablerecruiting
NCT03587623
Copeptin Serum Level in Liver Transplant RecipientsNo drug interventionsNot AvailableNot Availablecompleted
NCT01884038
Safety and Efficacy of Perioperative Remodulin® in Orthotopic Liver Transplant Recipientsprevention2 / 3withdrawn
NCT03527238
Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicinesupportive_care2completed
NCT00171743
Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipientsprevention4completed
NCT03636321
Stented Biliary Anastomosis in Living Donor Liver TransplantationNo drug interventionstreatmentNot Availablecompleted
NCT01230502
Mycophenolic Acid (MPA) Monotherapy in Liver TransplantationtreatmentNot Availableterminated
NCT02057484
A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney TransplantNot AvailableNot Availablecompleted
NCT02040584
A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.No drug interventionstreatment3completed
NCT02776553
A Physical Activity Program in End-state Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT02058498
Increasing Activity in Liver Transplant PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00371605
An Assessment of Voriconazole Pharmacokinetics and Pharmacogenetics in Liver Transplant Recipients - Pilot StudyNo drug interventionsNot AvailableNot Availableterminated
NCT02798861
Controlled Attenuation Parameter (CAP) in Liver AllograftsNo drug interventionsNot AvailableNot Availablecompleted
NCT02743793
A Cohort Study of Operationally Tolerant Allograft RecipientsNo drug interventionsNot AvailableNot Availableterminated
NCT04721288
REmote moBile Outpatient mOnitoring in Transplant 2.0No drug interventionspreventionNot Availablenot_yet_recruiting
NCT05275907
Mechanism of Hypertension Treatments in Liver Transplant Recipients (BLOCK LTR-HTN)other4withdrawn
NCT00171509
Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipientsprevention4completed
NCT04695756
Liver Transplantation and Coronavirus Disease 2019 (COVID-19)No drug interventionsNot AvailableNot Availableunknown_status
NCT03942315
Recurrence of Hereditary Hemorrhagic Telangiectasia (HHT) After Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT04194437
OCS Liver DCD TrialNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT05096741
OCS Liver PROTECT Continuation Post-Approval StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT04471441
Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients.treatment4unknown_status
NCT04312958
Quantra QStat in Trauma and Liver TransplantNo drug interventionsNot AvailableNot Availablecompleted
NCT06088758
Normothermic Machine Perfusion of Steatotic Livers for Expansion of Donor Organ PoolNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT04945135
Controlled Donors After Circulatory Death and Brain Death: a Multicenter Study of Transfusion, One-year Graft Survival and Mortality. Cohort Study,No drug interventionsNot AvailableNot Availablecompleted
NCT00677625
Pediatric Liver DatabaseNo drug interventionsNot AvailableNot Availablecompleted
NCT06254248
Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular CarcinomaNo drug interventionstreatment2not_yet_recruiting
NCT00275548
Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis Cprevention4completed
NCT00780026
Intraoperative Glucose Control in Liver Transplantsupportive_care4completed
NCT01696331
Text Messaging for Adherence in Adolescent Liver Transplant RecipientsNo drug interventionshealth_services_researchNot Availablecompleted
NCT03577431
Liver Transplantation With Tregs at MGHtreatment1 / 2active_not_recruiting
NCT02718573
Impact of Interferon-free Treatment for Hepatitis C Virus (HCV) on Blood Cells and Factors in BloodNo drug interventionsNot AvailableNot Availablecompleted
NCT04035876
Combination Camrelizumab (SHR-1210) and Apatinib for Downstaging/Bridging of HCC Before Liver Transplanttreatment1 / 2unknown_status
NCT05074160
OCS Liver Perfusion (OLP) Post-Approval RegistryNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00149994
Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipientsprevention4completed
NCT03666689
Outflow Reconstruction in Right Lobe Living Donor Liver TransplantationNo drug interventionsNot AvailableNot Availableunknown_status
NCT06183892
Prospective, Multicenter Clinical Study of Prolonged-release Tacrolimus in Stable Pediatric Liver Transplant RecipientstreatmentNot Availablenot_yet_recruiting
NCT00238901
Efficacy and Safety of Basiliximab in Hepatitis C Virus Positive Patients Undergoing Liver Transplantationprevention3completed
NCT02429869
Impact of Everolimus on HIV Persistence Post Kidney or Liver Transplantbasic_science4completed
NCT01840514
Cardiac Functions in Living Donor Liver Transplant Recipients. An Echocardiographic Study.No drug interventionsNot AvailableNot Availableunknown_status
NCT04204850
Cabozantinib to Treat Recurrent Liver Cancer Post Transplanttreatment2recruiting
NCT02863250
Australian and New Zealand Massive Transfusion RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT00260208
Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimusprevention4terminated